|
1
|
Zimmet P, Alberti KG and Shaw J: Global
and societal implications of the diabetes epidemic. Nature.
414:782–787. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Voulgari C, Papadogiannis D and
Tentolouris N: Diabetic cardiomyopathy: from the pathophysiology of
the cardiac myocytes to current diagnosis and management
strategies. Vasc Health Risk Manag. 6:883–903. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bugger H and Abel ED: Mitochondria in the
diabetic heart. Cardiovasc Res. 88:229–240. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Duncan JG: Mitochondrial dysfunction in
diabetic cardiomyopathy. Biochim Biophys Acta. 1813:1351–1359.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Huang P, Galloway CA and Yoon Y: Control
of mitochondrial morphology through differential interactions of
mitochondrial fusion and fission proteins. PLoS One. 6:e206552011.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bach D, Naon D, Pich S, Soriano FX, Vega
N, Rieusset J, Laville M, Guillet C, Boirie Y, Wallberg-Henriksson
H, Manco M, Calvani M, Castagneto M, Palacín M, Mingrone G, Zierath
JR, Vidal H and Zorzano A: Expression of Mfn2, the
Charcot-Marie-Tooth neuropathy type 2A gene, in human skeletal
muscle: effects of type 2 diabetes, obesity, weight loss, and the
regulatory role of tumor necrosis factor alpha and interleukin-6.
Diabetes. 54:2685–2693. 2005. View Article : Google Scholar
|
|
7
|
Tang WX, Wu WH, Zeng XX, Bo H and Huang
SM: Early protective effect of mitofusion 2 overexpression in
STZ-induced diabetic rat kidney. Endocrine. 41:236–247. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Papanicolaou KN, Khairallah RJ, Ngoh GA,
Chikando A, Luptak I, O’Shea KM, Riley DD, Lugus JJ, Colucci WS,
Lederer WJ, Stanley WC and Walsh K: Mitofusin-2 maintains
mitochondrial structure and contributes to stress-induced
permeability transition in cardiac myocytes. Mol Cell Biol.
31:1309–1328. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Cai L and Kang YJ: Oxidative stress and
diabetic cardiomyopathy: a brief review. Cardiovasc Toxicol.
1:181–193. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wold LE, Ceylan-Isik AF and Ren J:
Oxidative stress and stress signaling: menace of diabetic
cardiomyopathy. Acta Pharmacol Sin. 26:908–917. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Pich S, Bach D, Briones P, Liesa M, Camps
M, et al: The Charcot-Marie-Tooth type 2A gene product, Mfn2,
up-regulates fuel oxidation through expression of OXPHOS system.
Hum Mol Genet. 14:1405–1415. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bach D, Pich S, Soriano FX, Vega N,
Baumgartner B, et al: Mitofusin-2 determines mitochondrial network
architecture and mitochondrial metabolism. A novel regulatory
mechanism altered in obesity. J Biol Chem. 278:17190–17197. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chen H, Chomyn A and Chan DC: Disruption
of fusion results in mitochondrial heterogeneity and dysfunction. J
Biol Chem. 280:26185–26192. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wan-Xin T, Tian-Lei C, Ben W, Wei-Hua W
and Ping F: Effect of mitofusin 2 overexpression on the
proliferation and apoptosis of high-glucose-induced rat glomerular
mesangial cells. J Nephrol. Feb 7–2012.(Epub ahead of print).
|
|
15
|
Wang W, Lu J, Zhu F, Wei J, Jia C, Zhang
Y, Zhou L, Xie H and Zheng S: Pro-apoptotic and anti-proliferative
effects of mitofusin-2 via Bax signaling in hepatocellular
carcinoma cells. Med Oncol. 29:70–76. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Shen T, Zheng M, Cao C, Chen C, Tang J,
Zhang W, Cheng H, Chen KH and Xiao RP: Mitofusin-2 is a major
determinant of oxidative stress-mediated heart muscle cell
apoptosis. J Biol Chem. 282:23354–23361. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gall JM, Wang Z, Liesa M, Molina A, Havasi
A, Schwartz JH, Shirihai O, Borkan SC and Bonegio RG: Role of
mitofusin 2 in the renal stress response. PLoS One. 7:e310742012.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Fang L, Moore XL, Gao XM, Dart AM, Lim YL
and Du XJ: Down-regulation of mitofusin-2 expression in cardiac
hypertrophy in vitro and in vivo. Life Sci. 80:2154–2160. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chen KH, Guo X, Ma D, Guo Y, Li Q, Yang D,
Li P, Qiu X, Wen S, Xiao RP and Tang J: Dysregulation of HSG
triggers vascular proliferative disorders. Nat Cell Biol.
6:872–883. 2004. View
Article : Google Scholar : PubMed/NCBI
|
